FDA
-
-
-
-
-
-
-
Lannett (LCI) Granted FDA Approval to Manufacture Numbrino at Seymour Plant
-
-
-
-
-
-
-
LANNETT ENTERS AGREEMENT TO BE EXCLUSIVE U.S. DISTRIBUTOR OF FLUDARABINE PHOSPATE FOR INJECTION, USP
-
-
-
-
-
-
-
LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE
-
-
-
-
-
-
-
After-Hours Stock Movers 08/25: (WSM) (AMRX) (ZUO) Higher; (LCI) (SLQT) (ADSK) Lower (more...)
-
-
-
-
-
-
-
Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan Facility
-
-
-
-
-
-
-
Lannett (LCI) Expands Strategic Relationship with HEC To Include Biosimilar Fast-Acting Insulin
-
-
-
-
-
-
-
Lannett Announces Fiscal 2020 Fourth-Quarter, Full-Year Financial Results
-
251,860 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All